| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $12.0M | -53.3% |
| SG&A Expense | $10.7M | -27.9% |
| Operating Income | -$22.7M | +44.0% |
| Pre-tax Income | -$21.9M | +44.2% |
| Net Income | -$21.9M | +44.2% |
| EPS (Basic) | -$3.50 | -257.1% |
| EPS (Diluted) | -$3.50 | -257.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.5M | +2.3% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $38.0M | -15.9% |
| Total Assets | $38.0M | -15.9% |
| Current Liabilities | $6.2M | +2.1% |
| Total Liabilities | $6.2M | +2.1% |
| Stockholders' Equity | $31.8M | -18.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.5M | +55.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $7.8M | -89.5% |
| Financing Cash Flow | $13.6M | — |
| Free Cash Flow | -$20.5M | +55.3% |